After-Hours Stock Movers 06/08: (LYRA) (FSR) (LMNR) Higher; (ONDS) (CMTL) (PATH) Lower (more...)

June 8, 2021 5:54 PM EDT
Get Alerts LYRA Hot Sheet
Price: $8.66 -4.31%

Overall Analyst Rating:
    BUY (= Flat)

Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

After-Hours Stock Movers

Lyra Therapeutics, Inc. (Nasdaq: LYRA) 11% HIGHER; announced the successful outcome of an End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) for LYR-210, its lead candidate for the treatment of chronic rhinosinusitis (CRS).

Ondas Holdings Inc. (NASDAQ: ONDS) 14.7% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering

Comtech Telecom (NASDAQ: CMTL) 8% LOWER; reported Q3 EPS of $0.26, $0.27 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $139.4 million versus the consensus estimate of $140.39 million.

UiPath Inc. (NYSE: PATH) 7.9% LOWER; reported Q1 EPS of $0.02, versus ($0.09) reported last year. Revenue for the quarter came in at $186.2 million, versus $113.1 million reported last year. UiPath Inc. sees Q2 2022 revenue of $180-185 million.

Clarivate Plc (NYSE: CLVT) 7.6% LOWER; announced today that it has commenced concurrent proposed offerings of $750 million of ordinary shares, alongside which certain existing shareholders intend to offer $250 million of ordinary shares, and $1.25 billion of Series A Mandatory Convertible preferred shares.

Lordstown Motors (NASDAQ: RIDE) 4.7% LOWER; RBC Capital initiated coverage with an Underperform rating and a price target of $5.00.

Option Care Health, Inc. (NASDAQ: OPCH) 4.2% LOWER; announced today that an affiliate of Madison Dearborn Partners has agreed to sell 10,000,000 shares of the Company’s common stock in an underwritten public offering

Calavo Growers (NASDAQ: CVGW) 3.9% LOWER; reported Q2 EPS of $0.43, $0.01 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $276.8 million versus the consensus estimate of $267.07 million. The Company is providing the following expectations for the third fiscal quarter of 2021: Revenue in a range of $280 million to $300 million; and Adjusted EBITDA in a range of $11 million to $15 million.

CEL-SCI Corporation (NYSE: CVM) 3.6% LOWER; agreed to purchase on a firm commitment basis a minimum of 1,000,000 shares of common stock of the Company, at a price to the public of $22.62 per share (the “Public Price”), representing a 5% discount to the Company’s June 8, 2021 closing share price.

Fisker (NYSE: FSR) 3.5% HIGHER; RBC Capital initiates coverage with an Outperform rating and a price target of $27.00.

Limoneira (NASDAQ: LMNR) 3.5% HIGHER; reported Q2 EPS of $0.10, $0.04 better than the analyst estimate of $0.06. Revenue for the quarter came in at $45.1 million versus the consensus estimate of $45.44 million.

8x8, Inc. (NYSE: EGHT) 3.5% HIGHER; CEO, David Sipes, bought 43,000 shares on 06/07 at $23.47.

Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) 2% HIGHER; announced that the U.S Patent and Trademark Office issued a patent covering methods of using ARCALYST® (rilonacept) in the treatment of recurrent pericarditis.

Aclaris Therapeutics, Inc. (Nasdaq: ACRS) 2% LOWER; announced that it intends to offer and sell, subject to market conditions, $75 million in shares of its common stock in an underwritten public offering



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

RBC Capital, Madison Dearborn Partners, After-Hours Movers, FDA